Sanofi to buy US biopharma group Blueprint for up to $9.5 billion
The two companies said on Monday that Sanofi (SASY.PA) would initially pay $129.00 per share in cash, or around $9.1 billion.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
